COVID-19

Views & Analysis

Ardelyx’s ambition to revolutionise kidney treatment

A therapy to treat hyperphosphatemia is moving closer to the market after years of development by California-based company Ardelyx.

News

EUSA Pharma hopes IL-6 drug will succeed in COVID-19 where r...

UK-based EUSA Pharma has begun a late-stage trial of its antibody siltuximab in COVID-19, hoping that the IL-6 inhibitor will succeed where class rivals from Roche and Sanofi/Regeneron have

News

Trials of Valneva COVID-19 vaccine begin in UK

Trials of a fifth COVID-19 vaccine have begun in the UK, as IT issues threaten to delay the roll-out of the shot from Pfizer/BioNTech.

Views & Analysis

ABPI chief exec on the UK industry’s learnings from COVID-19

The ABPI’s chief executive Dr Richard Torbett shares his views on how the industry has adapted to COVID-19 and explains why the post-pandemic future is looking bright for the UK industry.

News

AbbVie begins trials of COVID-19 antibody therapy

AbbVie is to begin clinical development of an antibody designed to neutralise the SARS-CoV-2 coronavirus after licensing the therapy in from Harbour BioMed and Utrecht University.<

News

FDA backs Moderna COVID-19 shot ahead of emergency use vote

Moderna looks odds on to claim emergency use authorisation from the FDA for its COVID-19 vaccine this week, after the regulator published a report endorsing its safety and rating its effica

Ardelyx’s ambition to revolutionise kidney treatment

EUSA Pharma hopes IL-6 drug will succeed in COVID-19 where r...

Trials of Valneva COVID-19 vaccine begin in UK

ABPI chief exec on the UK industry’s learnings from COVID-19

AbbVie begins trials of COVID-19 antibody therapy

FDA backs Moderna COVID-19 shot ahead of emergency use vote

NHS to offer Wegovy to a million more people in England

Using AI-driven synthetic personas to take your insights fur...

COVID-19

Editor's Picks